HLA class I expression and its alteration by preoperative hyperthermo-chemoradiotherapy in patients with rectal cancer

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Sato, Hiro ^a   Suzuki, Yoshiyuki ^a   Ide, Munenori ^a   Katoh, Toshihide ^a   Noda, Shin Ei ^a   Ando, Ken ^a   Oike, Takahiro ^a   Yoshimoto, Yuya ^a   Okonogi, Noriyuki ^a   Mimura, Kousaku ^b   Asao, Takayuki ^a   Kuwano, Hiroyuki ^a   Nakano, Takashi ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CAPECITABINE; FLUOROURACIL; FOLINIC ACID; HLA ANTIGEN CLASS 1; LEVOLEUCOVORIN; UFT;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER TISSUE; CHEMORADIOTHERAPY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; HYPERTHERMIC THERAPY; HYPERTHERMO CHEMORADIOTHERAPY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS FREE SURVIVAL; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREOPERATIVE CARE; PROGNOSIS; RECTUM CARCINOMA; TUMOR CELL; VERY ELDERLY; CANCER GRADING; GENE EXPRESSION; GENETICS; IMMUNOLOGY; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RECTAL NEOPLASMS;

ADULT; AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY; COMBINED MODALITY THERAPY; FEMALE; GENE EXPRESSION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; HYPERTHERMIA, INDUCED; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; RECTAL NEOPLASMS;

EID: 84907907760     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108122     Document Type: Article

References (23)

1. Naito Y, Saito K, Shiiba K, Ohuchi A, Saigenji K, et al. (1998) CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 58: 3491-3494.
2. Khong HT, Restifo NP (2002) Natural selection of tumor variants in the generation of "tumor escape" phenotypes. Nat Immunol 3: 999-1005.
3. Ogino T, Bandoh N, Hayashi T, Miyokawa N, Harabuchi Y, et al. (2003) Association of tapasin and HLA class I antigen down-regulation in primary maxillary sinus squamous cell carcinoma lesions with reduced survival of patients. Clin Cancer Res 9: 4043-4051.
4. Ogino T, Shigyo H, Ishii H, Katayama A, Miyokawa N, et al. (2006) HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker. Cancer Res 66: 9281-9289.
5. Kikuchi E, Yamazaki K, Torigoe T, Cho Y, Miyamoto M, et al. (2007) HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancer. Cancer Sci 98: 1424-1430.
6. Mizukami Y, Kono K, Maruyama T, Watanabe M, Kawaguchi Y, et al. (2008) Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma. Br J Cancer 99: 1462-1467.
7. Homma I, Kitamura H, Torigoe T, Tanaka T, Sato E, et al. (2009) Human leukocyte antigen class I down-regulation in muscle-invasive bladder cancer: its association with clinical characteristics and survival after cystectomy. Cancer Sci 100: 2331-2334.
8. Bandoh N, Ogino T, Katayama A, Takahara M, Katada A, et al. (2010) HLA class I antigen and transporter associated with antigen processing downregulation in metastatic lesions of head and neck squamous cell carcinoma as a marker of poor prognosis. Oncol Rep 23: 933-939.
9. Lee Y, Auh SL, Wang Y, Burnette B, Wang Y, et al. (2009) Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. Blood 114: 589-595.
10. Takeshima T, Chamoto K, Wakita D, Ohkuri T, Togashi Y, et al. (2010) Local radiation therapy inhibits tumor growth through the generation of tumorspecific CTL: its potentiation by combination with Th1 cell therapy. Cancer Res 70: 2697-2706.
11. Suzuki Y, Mimura K, Yoshimoto Y, Watanabe M, Ohkubo Y, et al. (2012) Immunogenic tumor cell death induced by chemoradiotherapy in patients with esophageal squamous cell carcinoma. Cancer Res 72: 3967-3976.
12. Reits EA, Hodge JW, Herberts CA, Groothuis TA, Chakraborty M, et al. (2006) Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J Exp Med 203: 1259-1271.
13. Speetjens FM, de Bruin EC, Morreau H, Zeestraten EC, Putter H, et al. (2008) Clinical impact of HLA class I expression in rectal cancer. Cancer Immunol Immunother 57: 601-609.
14. Garnett CT, Palena C, Chakraborty M, Tsang KY, Schlom J, et al. (2004) Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes. Cancer Res 64: 7985-7994.
15. Newcomb EW, Demaria S, Lukyanov Y, Shao Y, Schnee T, et al. (2006) The combination of ionizing radiation and peripheral vaccination produces longterm survival of mice bearing established invasive GL261 gliomas. Clin Cancer Res 12: 4730-4737.
16. Shioya M, Takahashi T, Ishikawa H, Sakurai H, Ebara T, et al. (2011) Expression of hypoxia-inducible factor 1alpha predicts clinical outcome after preoperative hyperthermo-chemoradiotherapy for locally advanced rectal cancer. J Radiat Res 52: 821-827.
17. Tsutsumi S, Tabe Y, Fujii T, Yamaguchi S, Suto T, et al. (2011) Tumor response and negative distal resection margins of rectal cancer after hyperthermochemoradiation therapy. Anticancer Res 31: 3963-3967.
18. Tsukahara T, Kawaguchi S, Torigoe T, Asanuma H, Nakazawa E, et al. (2006) Prognostic significance of HLA class I expression in osteosarcoma defined by anti-pan HLA class I monoclonal antibody, EMR8-5. Cancer Sci 97: 1374-1380.
19. Watson NF, Ramage JM, Madjd Z, Spendlove I, Ellis IO, et al. (2006) Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis. Int J Cancer 118: 6-10.
20. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD (2002) Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 3: 991-998.
21. Abdel-Wahab Z, Dar MM, Hester D, Vervaert C, Gangavalli R, et al. (1996) Effect of irradiation on cytokine production, MHC antigen expression, and vaccine potential of interleukin-2 and interferon-gamma gene-modified melanoma cells. Cell Immunol 171: 246-254.
22. Gameiro SR, Higgins JP, Dreher MR, Woods DL, Reddy G, et al. (2013) Combination therapy with local radiofrequency ablation and systemic vaccine enhances antitumor immunity and mediates local and distal tumor regression. PLoS One 8: e70417.
23. Ohtsukasa S, Okabe S, Yamashita H, Iwai T, Sugihara K (2003) Increased expression of CEA and MHC class I in colorectal cancer cell lines exposed to chemotherapy drugs. J Cancer Res Clin Oncol 129: 719-726.